{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:41:52Z","timestamp":1792788112853,"version":"4.5.0"},"reference-count":170,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s40257-025-00953-9","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T08:40:37Z","timestamp":1749631237000},"page":"677-694","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["What\u2019s New in Wound Healing: Treatment Advances and Microbial Insights"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8207-396X","authenticated-orcid":false,"given":"Gabriela E.","family":"Beraja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Gruzmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Pastar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6223-7001","authenticated-orcid":false,"given":"Hadar","family":"Lev-Tov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"issue":"3","key":"953_CR1","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1524-475X.2012.00791.x","volume":"20","author":"LE Edsberg","year":"2012","unstructured":"Edsberg LE, Wyffels JT, Brogan MS, Fries KM. Analysis of the proteomic profile of chronic pressure ulcers. Wound Repair Regen. 2012;20(3):378\u2013401. https:\/\/doi.org\/10.1111\/j.1524-475X.2012.00791.x.","journal-title":"Wound Repair Regen"},{"issue":"9","key":"953_CR2","doi-asserted-by":"publisher","first-page":"4758","DOI":"10.1021\/pr100456d","volume":"9","author":"SA Eming","year":"2010","unstructured":"Eming SA, Koch M, Krieger A, et al. Differential proteomic analysis distinguishes tissue repair biomarker signatures in wound exudates obtained from normal healing and chronic wounds. J Proteome Res. 2010;9(9):4758\u201366. https:\/\/doi.org\/10.1021\/pr100456d.","journal-title":"J Proteome Res"},{"issue":"5","key":"953_CR3","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/j.1365-2133.2008.08462.x","volume":"158","author":"EA Rayment","year":"2008","unstructured":"Rayment EA, Upton Z, Shooter GK. Increased matrix metalloproteinase-9 (MMP-9) activity observed in chronic wound fluid is related to the clinical severity of the ulcer. Br J Dermatol. 2008;158(5):951\u201361. https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08462.x.","journal-title":"Br J Dermatol"},{"key":"953_CR4","doi-asserted-by":"publisher","unstructured":"Doerfler P, Schoefmann N, Cabral G, et al. Development of a cellular assay as a personalized model for testing chronic wound therapeutics. J Invest Dermatol. Published online July 1, 2024. https:\/\/doi.org\/10.1016\/j.jid.2024.05.029.","DOI":"10.1016\/j.jid.2024.05.029"},{"key":"953_CR5","doi-asserted-by":"publisher","unstructured":"Jozic I, Tomic-Canic M. Flipping the script: are cellular assays and wound fluids the next frontier in personalized wound care? J Invest Dermatol. Published online September 14, 2024. https:\/\/doi.org\/10.1016\/j.jid.2024.08.007.","DOI":"10.1016\/j.jid.2024.08.007"},{"key":"953_CR6","unstructured":"ClinicalTrials.gov. A portable, disposable, non-invasive, and non-contact device for monitoring wound alkalinity in diabetic foot ulcers, pressure ulcers, and venous leg ulcers. NCT04614038. https:\/\/clinicaltrials.gov\/study\/NCT04614038?cond=Wounds%20and%20Injuries&term=diabetic%20foot%20ulcers&aggFilters=status:not%20rec&rank=18. Accessed 3 Feb 2025."},{"issue":"2","key":"953_CR7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s13671-022-00354-9","volume":"11","author":"V Chen","year":"2022","unstructured":"Chen V, Burgess JL, Verpile R, Tomic-Canic M, Pastar I. Novel diagnostic technologies and therapeutic approaches targeting chronic wound biofilms and microbiota. Curr Dermatol Rep. 2022;11(2):60\u201372. https:\/\/doi.org\/10.1007\/s13671-022-00354-9.","journal-title":"Curr Dermatol Rep"},{"issue":"5","key":"953_CR8","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.chom.2019.03.006","volume":"25","author":"LR Kalan","year":"2019","unstructured":"Kalan LR, Meisel JS, Loesche MA, et al. Strain- and species-level variation in the microbiome of diabetic wounds is associated with clinical outcomes and therapeutic efficacy. Cell Host Microbe. 2019;25(5):641-655.e5. https:\/\/doi.org\/10.1016\/j.chom.2019.03.006.","journal-title":"Cell Host Microbe"},{"issue":"7","key":"953_CR9","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/apm.13226","volume":"130","author":"M Radzieta","year":"2022","unstructured":"Radzieta M, Peters TJ, Dickson HG, et al. A metatranscriptomic approach to explore longitudinal tissue specimens from non-healing diabetes related foot ulcers. APMIS. 2022;130(7):383\u201396. https:\/\/doi.org\/10.1111\/apm.13226.","journal-title":"APMIS"},{"issue":"1","key":"953_CR10","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.cmi.2020.07.021","volume":"27","author":"T Ojala","year":"2021","unstructured":"Ojala T, Lindford A, Savijoki K, et al. Metatranscriptomic assessment of burn wound infection clearance. Clin Microbiol Infect. 2021;27(1):144\u20136. https:\/\/doi.org\/10.1016\/j.cmi.2020.07.021.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"953_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/wrr.12370","volume":"24","author":"RD Wolcott","year":"2016","unstructured":"Wolcott RD, Hanson JD, Rees EJ, et al. Analysis of the chronic wound microbiota of 2,963 patients by 16S rDNA pyrosequencing. Wound Repair Regen. 2016;24(1):163\u201374. https:\/\/doi.org\/10.1111\/wrr.12370.","journal-title":"Wound Repair Regen"},{"key":"953_CR12","doi-asserted-by":"publisher","unstructured":"Campbell A, Bae J, Hein M, et al. The heterogeneous wound microbiome varies with wound care pain, dressing type, and inflammatory gene expression. Wound Repair Regen. Published online April 26, 2024. https:\/\/doi.org\/10.1111\/wrr.13184.","DOI":"10.1111\/wrr.13184"},{"key":"953_CR13","doi-asserted-by":"publisher","unstructured":"Dini\u0107 M, Verpile R, Burgess JL, et al. Multi-drug resistant Staphylococcus epidermidis from chronic wounds impair healing in human wound model. Wound Repair Regen. Published online October 22, 2024. https:\/\/doi.org\/10.1111\/wrr.13231.","DOI":"10.1111\/wrr.13231"},{"issue":"26","key":"953_CR14","doi-asserted-by":"publisher","first-page":"eadj2020","DOI":"10.1126\/sciadv.adj2020","volume":"10","author":"EK White","year":"2024","unstructured":"White EK, Uberoi A, Pan JT, et al. Alcaligenes faecalis corrects aberrant matrix metalloproteinase expression to promote reepithelialization of diabetic wounds. Sci Adv. 2024;10(26):eadj2020. https:\/\/doi.org\/10.1126\/sciadv.adj2020.","journal-title":"Sci Adv"},{"issue":"12","key":"953_CR15","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1111\/j.1469-0691.2010.03158.x","volume":"16","author":"JH Melendez","year":"2010","unstructured":"Melendez JH, Frankel YM, An AT, et al. Real-time PCR assays compared to culture-based approaches for identification of aerobic bacteria in chronic wounds. Clin Microbiol Infect. 2010;16(12):1762\u20139. https:\/\/doi.org\/10.1111\/j.1469-0691.2010.03158.x.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"953_CR16","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1089\/wound.2019.1103","volume":"10","author":"S Li","year":"2021","unstructured":"Li S, Renick P, Senkowsky J, Nair A, Tang L. Diagnostics for wound infections. Adv Wound Care (New Rochelle). 2021;10(6):317\u201327. https:\/\/doi.org\/10.1089\/wound.2019.1103.","journal-title":"Adv Wound Care (New Rochelle)"},{"issue":"5","key":"953_CR17","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1128\/JCM.42.5.1875-1884.2004","volume":"42","author":"A Huletsky","year":"2004","unstructured":"Huletsky A, Giroux R, Rossbach V, et al. New real-time PCR assay for rapid detection of methicillin-resistant Staphylococcus aureus directly from specimens containing a mixture of staphylococci. J Clin Microbiol. 2004;42(5):1875\u201384. https:\/\/doi.org\/10.1128\/JCM.42.5.1875-1884.2004.","journal-title":"J Clin Microbiol"},{"issue":"9","key":"953_CR18","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1001\/jamadermatol.2017.0904","volume":"153","author":"HC Ring","year":"2017","unstructured":"Ring HC, Thorsen J, Saunte DM, et al. The follicular skin microbiome in patients with hidradenitis suppurativa and healthy controls. JAMA Dermatol. 2017;153(9):897\u2013905. https:\/\/doi.org\/10.1001\/jamadermatol.2017.0904.","journal-title":"JAMA Dermatol"},{"issue":"2","key":"953_CR19","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/jac\/dkv361","volume":"71","author":"O Join-Lambert","year":"2016","unstructured":"Join-Lambert O, Coignard-Biehler H, Jais JP, et al. Efficacy of ertapenem in severe hidradenitis suppurativa: a pilot study in a cohort of 30 consecutive patients. J Antimicrob Chemother. 2016;71(2):513\u201320. https:\/\/doi.org\/10.1093\/jac\/dkv361.","journal-title":"J Antimicrob Chemother"},{"key":"953_CR20","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1038\/jid.2010.123","volume":"130","author":"Y Lai","year":"2010","unstructured":"Lai Y, Cogen AL, Radek KA, Park HJ, MacLeod DT, Leichtle A, Ryan AF, Di Nardo A, Gallo RL. Activation of TLR2 by a small molecule produced by Staphylococcus epidermidis increases antimicrobial defense against bacterial skin infections. J Invest Dermatol. 2010;130:2211\u201321. https:\/\/doi.org\/10.1038\/jid.2010.123.","journal-title":"J Invest Dermatol"},{"key":"953_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058288","volume":"8","author":"D Li","year":"2013","unstructured":"Li D, Lei H, Li Z, Li H, Wang Y, Lai Y. A novel lipopeptide from skin commensal activates TLR2\/CD36-p38 MAPK signaling to increase antibacterial defense against bacterial infection. PLoS ONE. 2013;8:e58288. https:\/\/doi.org\/10.1371\/journal.pone.0058288.","journal-title":"PLoS ONE"},{"key":"953_CR22","doi-asserted-by":"publisher","unstructured":"Pastar I, O\u2019Neill K, Padula L, et al. Staphylococcus epidermidis boosts innate immune response by activation of gamma delta T cells and induction of perforin-2 in human skin [published correction appears in Front Immunol. 2021 Aug 10;12:741437. https:\/\/doi.org\/10.3389\/fimmu.2021.741437]. Front Immunol. 2020;11:550946. Published 2020 Sep 16. https:\/\/doi.org\/10.3389\/fimmu.2020.550946.","DOI":"10.3389\/fimmu.2021.741437"},{"issue":"7","key":"953_CR23","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.2337\/dc21-2218","volume":"45","author":"S Rahma","year":"2022","unstructured":"Rahma S, Woods J, Brown S, Nixon J, Russell D. The use of point-of-care bacterial autofluorescence imaging in the management of diabetic foot ulcers: a pilot randomized controlled trial. Diabetes Care. 2022;45(7):1601\u20139. https:\/\/doi.org\/10.2337\/dc21-2218.","journal-title":"Diabetes Care"},{"issue":"3","key":"953_CR24","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.cpm.2018.02.005","volume":"35","author":"AS Landsman","year":"2018","unstructured":"Landsman AS, Barnhart D, Sowa M. Near-infrared spectroscopy imaging for assessing skin and wound oxygen perfusion. Clin Podiatr Med Surg. 2018;35(3):343\u201355. https:\/\/doi.org\/10.1016\/j.cpm.2018.02.005.","journal-title":"Clin Podiatr Med Surg"},{"issue":"6","key":"953_CR25","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/wrr.12853","volume":"28","author":"P Longobardi","year":"2020","unstructured":"Longobardi P, Hartwig V, Santarella L, et al. Potential markers of healing from near infrared spectroscopy imaging of venous leg ulcer. A randomized controlled clinical trial comparing conventional with hyperbaric oxygen treatment. Wound Repair Regen. 2020;28(6):856\u201366. https:\/\/doi.org\/10.1111\/wrr.12853.","journal-title":"Wound Repair Regen"},{"key":"953_CR26","doi-asserted-by":"publisher","unstructured":"Schultz GS, Barillo DJ, Mozingo DW, Chin GA; Wound Bed Advisory Board Members. Wound bed preparation and a brief history of TIME. Int Wound J. 2004;1(1):19\u201332. https:\/\/doi.org\/10.1111\/j.1742-481x.2004.00008.x.","DOI":"10.1111\/j.1742-481x.2004.00008.x"},{"issue":"S3","key":"953_CR27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/iwj.12662","volume":"13","author":"RL Harries","year":"2016","unstructured":"Harries RL, Bosanquet DC, Harding KG. Wound bed preparation: TIME for an update. Int Wound J. 2016;13(S3):8\u201314. https:\/\/doi.org\/10.1111\/iwj.12662.","journal-title":"Int Wound J"},{"issue":"4","key":"953_CR28","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/01.asw.0000733724.87630.d6","volume":"34","author":"RG Sibbald","year":"2021","unstructured":"Sibbald RG, Elliott JA, Persaud-Jaimangal R, et al. Wound bed preparation 2021. Adv Skin Wound Care. 2021;34(4):183\u201395. https:\/\/doi.org\/10.1097\/01.asw.0000733724.87630.d6.","journal-title":"Adv Skin Wound Care"},{"issue":"4","key":"953_CR29","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1177\/1534734612466871","volume":"11","author":"C Trial","year":"2012","unstructured":"Trial C, Brancati A, Marnet O, T\u00e9ot L. Coblation technology for surgical wound debridement: principle, experimental data, and technical data. Int J Low Extrem Wounds. 2012;11(4):286\u201392. https:\/\/doi.org\/10.1177\/1534734612466871.","journal-title":"Int J Low Extrem Wounds"},{"key":"953_CR30","unstructured":"Ennis WJ, Foremann P, Mozen N, Massey J, Conner-Kerr T, Meneses P. Ultrasound therapy for recalcitrant diabetic foot ulcers: results of a randomized, double-blind, controlled, multicenter study [published correction appears in Ostomy Wound Manage. 2005 Sep;51(9):14]. Ostomy Wound Manag. 2005;51(8):24\u201339."},{"issue":"5","key":"953_CR31","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/j.1742-481X.2011.00921.x","volume":"9","author":"J Escandon","year":"2012","unstructured":"Escandon J, Vivas AC, Perez R, Kirsner R, Davis S. A prospective pilot study of ultrasound therapy effectiveness in refractory venous leg ulcers. Int Wound J. 2012;9(5):570\u20138. https:\/\/doi.org\/10.1111\/j.1742-481X.2011.00921.x.","journal-title":"Int Wound J"},{"issue":"2","key":"953_CR32","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/iwj.13509","volume":"18","author":"Y Kataoka","year":"2021","unstructured":"Kataoka Y, Kunimitsu M, Nakagami G, Koudounas S, Weller CD, Sanada H. Effectiveness of ultrasonic debridement on reduction of bacteria and biofilm in patients with chronic wounds: a scoping review. Int Wound J. 2021;18(2):176\u201386. https:\/\/doi.org\/10.1111\/iwj.13509.","journal-title":"Int Wound J"},{"issue":"5","key":"953_CR33","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1111\/wrr.12595","volume":"25","author":"C Wiegand","year":"2017","unstructured":"Wiegand C, Bittenger K, Galiano RD, Driver VR, Gibbons GW. Does noncontact low-frequency ultrasound therapy contribute to wound healing at the molecular level? Wound Repair Regen. 2017;25(5):871\u201382. https:\/\/doi.org\/10.1111\/wrr.12595.","journal-title":"Wound Repair Regen"},{"issue":"8","key":"953_CR34","first-page":"50","volume":"54","author":"J Schmuckler","year":"2008","unstructured":"Schmuckler J. Acoustic pressure wound therapy to facilitate granulation tissue in sacral pressure ulcers in patients with compromised mobility: a case series. Ostomy Wound Manag. 2008;54(8):50\u20133.","journal-title":"Ostomy Wound Manag"},{"key":"953_CR35","unstructured":"Hiebert JM, Robson MC. The immediate and delayed post-debridement effects on tissue bacterial wound counts of hypochlorous acid versus saline irrigation in chronic wounds. Eplasty. 2016;16:e32. Published 2016 Dec 1."},{"issue":"5","key":"953_CR36","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/wrr.12738","volume":"27","author":"Y Mori","year":"2019","unstructured":"Mori Y, Nakagami G, Kitamura A, et al. Effectiveness of biofilm-based wound care system on wound healing in chronic wounds. Wound Repair Regen. 2019;27(5):540\u20137. https:\/\/doi.org\/10.1111\/wrr.12738.","journal-title":"Wound Repair Regen"},{"issue":"3","key":"953_CR37","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1080\/1120009X.2016.1205309","volume":"29","author":"S Esposito","year":"2017","unstructured":"Esposito S, De Simone G, Gioia R, et al. Deep tissue biopsy vs. superficial swab culture, including microbial loading determination, in the microbiological assessment of Skin and Soft Tissue Infections (SSTIs). J Chemother. 2017;29(3):154\u20138. https:\/\/doi.org\/10.1080\/1120009X.2016.1205309.","journal-title":"J Chemother"},{"issue":"10","key":"953_CR38","first-page":"267","volume":"21","author":"X Li","year":"2009","unstructured":"Li X, Liu S, Lai X, et al. A pilot study of ultrasonically-assisted treatment of residual burn wounds. Wounds. 2009;21(10):267\u201372.","journal-title":"Wounds"},{"issue":"4","key":"953_CR39","first-page":"62","volume":"54","author":"CP Fleming","year":"2008","unstructured":"Fleming CP. Acoustic pressure wound therapy in the treatment of a vasculopathy-associated digital ulcer: a case study. Ostomy Wound Manag. 2008;54(4):62\u20135.","journal-title":"Ostomy Wound Manag"},{"issue":"2","key":"953_CR40","first-page":"68","volume":"54","author":"T Serena","year":"2008","unstructured":"Serena T. Wound closure and gradual involution of an infantile hemangioma using a noncontact, low-frequency ultrasound therapy. Ostomy Wound Manag. 2008;54(2):68\u201371.","journal-title":"Ostomy Wound Manag"},{"issue":"1","key":"953_CR41","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/01.ASW.0000897440.98255.e5","volume":"36","author":"Y Luu","year":"2023","unstructured":"Luu Y, Han J, Owji S, et al. Accelerated healing from severe radiation dermatitis using noncontact, low-frequency ultrasound-assisted saline wash therapy. Adv Skin Wound Care. 2023;36(1):41\u20133. https:\/\/doi.org\/10.1097\/01.ASW.0000897440.98255.e5.","journal-title":"Adv Skin Wound Care"},{"issue":"5","key":"953_CR42","first-page":"50","volume":"54","author":"PA Liguori","year":"2008","unstructured":"Liguori PA, Peters KL, Bowers JM. Combination of negative pressure wound therapy and acoustic pressure wound therapy for treatment of infected surgical wounds: a case series. Ostomy Wound Manag. 2008;54(5):50\u20133.","journal-title":"Ostomy Wound Manag"},{"key":"953_CR43","doi-asserted-by":"publisher","unstructured":"Liu E, Hu X, Zhang W, et al. Efficacy and safety of ultrasound-assisted wound debridement in the treatment of diabetic foot ulcers: a systematic review and meta-analysis of 11 randomized controlled trials. Front Endocrinol (Lausanne). 2024;15:1393251. Published 2024 May 1. https:\/\/doi.org\/10.3389\/fendo.2024.1393251.","DOI":"10.3389\/fendo.2024.1393251"},{"issue":"3","key":"953_CR44","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.bjps.2008.11.097","volume":"63","author":"R Vanwijck","year":"2010","unstructured":"Vanwijck R, Kaba L, Boland S, Gonzales y Azero M, Delange A, Tourbach S. Immediate skin grafting of sub-acute and chronic wounds debrided by hydrosurgery. J Plast Reconstr Aesthet Surg. 2010;63(3):544\u20139. https:\/\/doi.org\/10.1016\/j.bjps.2008.11.097.","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"1","key":"953_CR45","doi-asserted-by":"publisher","first-page":"14","DOI":"10.37897\/RMJ.2022.1.3","volume":"69","author":"M Tiglis","year":"2022","unstructured":"Tiglis M, Peride I, Neagu TP, Raducu L, Lascar I. Hydrotherapy in burn care: pros, cons and suggestions. Revista medical\u0103 Rom\u00e2n\u0103. 2022;69(1):14\u20136. https:\/\/doi.org\/10.37897\/RMJ.2022.1.3.","journal-title":"Revista medical\u0103 Rom\u00e2n\u0103"},{"key":"953_CR46","doi-asserted-by":"publisher","unstructured":"Nandhagopal V, Chittoria R, Mohapatra D, Thiruvoth F, Shivakumar D, Ashokan A. Role of jet force technology in wound management. Plast Aesthet Res. 2015;2(5):277\u2013. https:\/\/doi.org\/10.4103\/2347-9264.165441.","DOI":"10.4103\/2347-9264.165441"},{"key":"953_CR47","doi-asserted-by":"publisher","unstructured":"Bowling FL, Stickings DS, Edwards\u2010Jones V, Armstrong DG, Boulton AJ. Hydrodebridement of wounds: effectiveness in reducing wound bacterial contamination and potential for air bacterial contamination. J Foot Ankle Res. 2009;2(1):13\u2013n\/a. https:\/\/doi.org\/10.1186\/1757-1146-2-13.","DOI":"10.1186\/1757-1146-2-13"},{"issue":"3","key":"953_CR48","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/ptj\/80.3.292","volume":"80","author":"KA Luedtke-Hoffmann","year":"2000","unstructured":"Luedtke-Hoffmann KA, Schafer DS. Pulsed lavage in wound cleansing. Phys Ther. 2000;80(3):292\u2013300.","journal-title":"Phys Ther"},{"issue":"4","key":"953_CR49","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/iwj.12137","volume":"12","author":"J Liu","year":"2015","unstructured":"Liu J, Ko JH, Secretov E, et al. Comparing the hydrosurgery system to conventional debridement techniques for the treatment of delayed healing wounds: a prospective, randomised clinical trial to investigate clinical efficacy and cost-effectiveness. Int Wound J. 2015;12(4):456\u201361. https:\/\/doi.org\/10.1111\/iwj.12137.","journal-title":"Int Wound J"},{"issue":"4","key":"953_CR50","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1093\/bjs\/znab470","volume":"109","author":"CM Legemate","year":"2022","unstructured":"Legemate CM, Kwa KAA, Goei H, et al. Hydrosurgical and conventional debridement of burns: randomized clinical trial. Br J Surg. 2022;109(4):332\u20139. https:\/\/doi.org\/10.1093\/bjs\/znab470.","journal-title":"Br J Surg"},{"issue":"3","key":"953_CR51","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/iwj.13528","volume":"18","author":"K Shimada","year":"2021","unstructured":"Shimada K, Ojima Y, Ida Y, Matsumura H. Efficacy of Versajet hydrosurgery system in chronic wounds: a systematic review. Int Wound J. 2021;18(3):269\u201378. https:\/\/doi.org\/10.1111\/iwj.13528.","journal-title":"Int Wound J"},{"issue":"2","key":"953_CR52","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1097\/BCR.0000000000000561","volume":"39","author":"DD Kakagia","year":"2018","unstructured":"Kakagia DD, Karadimas EJ. The efficacy of Versajet\u2122 hydrosurgery system in burn surgery. A systematic review. J Burn Care Res. 2018;39(2):188\u2013200. https:\/\/doi.org\/10.1097\/BCR.0000000000000561.","journal-title":"J Burn Care Res"},{"key":"953_CR53","volume-title":"Activa supplement edition","author":"KR Vowden","year":"2011","unstructured":"Vowden KR, Vowden P. Debrisoft: revolutionising debridement. In: Ltd AH, editor. Activa supplement edition. London: MA Healthcare Ltd; 2011."},{"issue":"3","key":"953_CR54","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/iwj.12045","volume":"10","author":"BM Madhok","year":"2013","unstructured":"Madhok BM, Vowden K, Vowden P. New techniques for wound debridement. Int Wound J. 2013;10(3):247\u201351. https:\/\/doi.org\/10.1111\/iwj.12045.","journal-title":"Int Wound J"},{"issue":"5","key":"953_CR55","doi-asserted-by":"publisher","first-page":"242","DOI":"10.12968\/jowc.2011.20.5.242","volume":"20","author":"S Bahr","year":"2011","unstructured":"Bahr S, Mustafi N, H\u00e4ttig P, et al. Clinical efficacy of a new monofilament fibre-containing wound debridement product. J Wound Care. 2011;20(5):242\u20138. https:\/\/doi.org\/10.12968\/jowc.2011.20.5.242.","journal-title":"J Wound Care"},{"issue":"6","key":"953_CR56","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.12968\/bjon.2011.20.Sup4.S35","volume":"20","author":"G Haemmerle","year":"2011","unstructured":"Haemmerle G, Duelli H, Abel M, Strohal R. The wound debrider: a new monofilament fibre technology. Br J Nurs. 2011;20(6):S35\u201342. https:\/\/doi.org\/10.12968\/bjon.2011.20.Sup4.S35.","journal-title":"Br J Nurs"},{"key":"953_CR57","doi-asserted-by":"publisher","unstructured":"Suraya AS, Kurniawati ND, Mariyanti H, Suarilah I. A systematic review of efficacy on larva debridement in diabetic foot ulcers. Healthcare in low-resource settings. Published online 2024. https:\/\/doi.org\/10.4081\/hls.2024.11839.","DOI":"10.4081\/hls.2024.11839"},{"key":"953_CR58","doi-asserted-by":"publisher","unstructured":"Pajarillo C, Sherman RA, Sheridan R, Kazis LE. Health professionals\u2019 perceptions of maggot debridement therapy. J Wound Care. 2021;30(Sup9a):VIIi\u2013VIIxi. https:\/\/doi.org\/10.12968\/jowc.2021.30.Sup9a.VII.","DOI":"10.12968\/jowc.2021.30.Sup9a.VII"},{"key":"953_CR59","doi-asserted-by":"publisher","unstructured":"Thomas DC, Tsu CL, Nain RA, Arsat N, Fun SS, Sahid Nik Lah NA. The role of debridement in wound bed preparation in chronic wound: a narrative review. Ann Med Surg (Lond). 2021;71:102876. Published 2021 Oct 4. https:\/\/doi.org\/10.1016\/j.amsu.2021.102876.","DOI":"10.1016\/j.amsu.2021.102876"},{"issue":"1","key":"953_CR60","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1177\/1534734621104429","volume":"23","author":"O Dehghan","year":"2024","unstructured":"Dehghan O, Tabaie SM, Rafinejad J, et al. A parallel randomized clinical trial for comparison of two methods of maggot therapy, free-range larvae and larval-bag, in diabetic ulcer (Wagner 2). Int J Lower Extrem Wounds. 2024;23(1):133\u20139. https:\/\/doi.org\/10.1177\/1534734621104429.","journal-title":"Int J Lower Extrem Wounds"},{"key":"953_CR61","doi-asserted-by":"publisher","first-page":"b773","DOI":"10.1136\/bmj.b77","volume":"338","author":"JC Dumville","year":"2009","unstructured":"Dumville JC, Worthy G, Bland JM, et al. Larval therapy for leg ulcers (VenUS II): randomised controlled trial. BMJ. 2009;338:b773. https:\/\/doi.org\/10.1136\/bmj.b77.","journal-title":"BMJ"},{"issue":"10","key":"953_CR62","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1177\/0268355514555386","volume":"30","author":"CE Davies","year":"2015","unstructured":"Davies CE, Woolfrey G, Hogg N, et al. Maggots as a wound debridement agent for chronic venous leg ulcers under graduated compression bandages: a randomised controlled trial. Phlebology. 2015;30(10):693\u20139. https:\/\/doi.org\/10.1177\/0268355514555386.","journal-title":"Phlebology"},{"issue":"4","key":"953_CR63","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1001\/archdermatol.2011.1895","volume":"148","author":"K Opletalova","year":"2012","unstructured":"Opletalova K, Blaizot X, Mourgeon B, et al. Maggot therapy for wound debridement: a randomized multicenter trial. Arch Dermatol. 2012;148(4):432\u20138. https:\/\/doi.org\/10.1001\/archdermatol.2011.1895.","journal-title":"Arch Dermatol"},{"issue":"1","key":"953_CR64","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/wrr.12127","volume":"22","author":"E Mudge","year":"2014","unstructured":"Mudge E, Price P, Walkley N, Harding KG. A randomized controlled trial of larval therapy for the debridement of leg ulcers: results of a multicenter, randomized, controlled, open, observer blind, parallel group study. Wound Repair Regen. 2014;22(1):43\u201351. https:\/\/doi.org\/10.1111\/wrr.12127.","journal-title":"Wound Repair Regen"},{"key":"953_CR65","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2147\/Cwcmr.S248149","volume":"7","author":"E Nezakati","year":"2020","unstructured":"Nezakati E, Hasani MH, Zolfaghari P, Rashidan M, Sohrabi MB. Effects of Lucilia sericata maggot therapy in chronic wound treatment: a randomized clinical trial. Chronic Wound Care Manag Res. 2020;7:11\u20137. https:\/\/doi.org\/10.2147\/Cwcmr.S248149.","journal-title":"Chronic Wound Care Manag Res"},{"issue":"1","key":"953_CR66","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/s12916-023-03063-7","volume":"21","author":"J Gaffari","year":"2023","unstructured":"Gaffari J, Akbarzadeh K, Baniardalani M, et al. Larval therapy vs conventional silver dressings for full-thickness burns: a randomized controlled trial. BMC Med. 2023;21(1):361. https:\/\/doi.org\/10.1186\/s12916-023-03063-7.","journal-title":"BMC Med"},{"issue":"1","key":"953_CR67","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/WON.0000000000000496","volume":"46","author":"A Malekian","year":"2019","unstructured":"Malekian A, Esmaeeli Djavid G, Akbarzadeh K, et al. Efficacy of maggot therapy on Staphylococcus aureus and Pseudomonas aeruginosa in diabetic foot ulcers: a randomized controlled trial. J Wound Ostomy Cont Nurs. 2019;46(1):25\u20139. https:\/\/doi.org\/10.1097\/WON.0000000000000496.","journal-title":"J Wound Ostomy Cont Nurs"},{"issue":"2","key":"953_CR68","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3390\/jcm14020315","volume":"14","author":"T Lam","year":"2025","unstructured":"Lam T, Beraja GE, Lev-Tov H. Efficacy of larval therapy for wounds: a systematic review and meta-analysis. J Clin Med. 2025;14(2):315. https:\/\/doi.org\/10.3390\/jcm14020315.","journal-title":"J Clin Med"},{"issue":"4","key":"953_CR69","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2165\/00128071-200102040-00003","volume":"2","author":"KY Mumcuoglu","year":"2001","unstructured":"Mumcuoglu KY. Clinical applications for maggots in wound care. Am J Clin Dermatol. 2001;2(4):219\u201327. https:\/\/doi.org\/10.2165\/00128071-200102040-00003.","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"953_CR70","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1093\/jbcr\/iraa074","volume":"41","author":"SH Salehi","year":"2020","unstructured":"Salehi SH, Momeni M, Vahdani M, Moradi M. Clinical value of debriding enzymes as an adjunct to standard early surgical excision in human burns: a systematic review. J Burn Care Res. 2020;41(6):1224\u201330. https:\/\/doi.org\/10.1093\/jbcr\/iraa074.","journal-title":"J Burn Care Res"},{"key":"953_CR71","doi-asserted-by":"publisher","unstructured":"Berner JE, Keckes D, Pywell M, Dheansa B. Limitations to the use of bromelain-based enzymatic debridement (NexoBrid\u00ae) for treating diabetic foot burns: a case series of disappointing results. Scars Burn Heal. 2018;4:2059513118816534. Published 2018 Dec 5. https:\/\/doi.org\/10.1177\/2059513118816534.","DOI":"10.1177\/2059513118816534"},{"issue":"5","key":"953_CR72","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/iwj.12925","volume":"15","author":"Y Shoham","year":"2018","unstructured":"Shoham Y, Krieger Y, Tamir E, et al. Bromelain-based enzymatic debridement of chronic wounds: a preliminary report. Int Wound J. 2018;15(5):769\u201375. https:\/\/doi.org\/10.1111\/iwj.12925.","journal-title":"Int Wound J"},{"issue":"17","key":"953_CR73","doi-asserted-by":"publisher","first-page":"8134","DOI":"10.3390\/app11178134","volume":"11","author":"M Pertea","year":"2021","unstructured":"Pertea M, Poroch V, Ciobanu P, Filip A, Velenciuc N, Lunca S, Panuta A, Buna-Arvinte M, Luca S, Veliceasa B. Efficiency of bromelain-enriched enzyme mixture (NexoBrid\u2122) in the treatment of burn wounds. Appl Sci. 2021;11(17):8134. https:\/\/doi.org\/10.3390\/app11178134.","journal-title":"Appl Sci"},{"issue":"6","key":"953_CR74","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/wrr.12958","volume":"29","author":"Y Shoham","year":"2021","unstructured":"Shoham Y, Shapira E, Haik J, et al. Bromelain-based enzymatic debridement of chronic wounds: results of a multicentre randomized controlled trial. Wound Repair Regen. 2021;29(6):899\u2013907. https:\/\/doi.org\/10.1111\/wrr.12958.","journal-title":"Wound Repair Regen"},{"key":"953_CR75","doi-asserted-by":"publisher","unstructured":"Shoham Y, Snyder RJ, Katz Levy Y, et al. Once daily Bromelain-based enzymatic debridement of venous leg ulcers versus gel vehicle (placebo) and non-surgical standard of care: a three-arm multicenter, double-blinded, randomized controlled study. EClinicalMedicine. 2024;102750. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102750.","DOI":"10.1016\/j.eclinm.2024.102750"},{"issue":"s136","key":"953_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/apm.12099","volume":"121","author":"T Bjarnsholt","year":"2013","unstructured":"Bjarnsholt T. The role of bacterial biofilms in chronic infections. APMIS: Acta Pathol Microbiol Immunol Scand. 2013;121(s136):1\u201358. https:\/\/doi.org\/10.1111\/apm.12099.","journal-title":"APMIS: Acta Pathol Microbiol Immunol Scand"},{"key":"953_CR77","doi-asserted-by":"publisher","unstructured":"Puca V, Marulli RZ, Grande R, et al. Microbial species isolated from infected wounds and antimicrobial resistance analysis: data emerging from a three-years retrospective study. Antibiotics (Basel). 2021;10(10):1162. Published 2021 Sep 24. https:\/\/doi.org\/10.3390\/antibiotics10101162.","DOI":"10.3390\/antibiotics10101162"},{"issue":"1","key":"953_CR78","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1089\/wound.2014.0593","volume":"5","author":"K Edwards","year":"2016","unstructured":"Edwards K. New twist on an old favorite: gentian violet and methylene blue antibacterial foams. Adv Wound Care (New Rochelle). 2016;5(1):11\u20138. https:\/\/doi.org\/10.1089\/wound.2014.0593.","journal-title":"Adv Wound Care (New Rochelle)"},{"issue":"8","key":"953_CR79","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1021\/es103450g","volume":"45","author":"TO Peulen","year":"2011","unstructured":"Peulen TO, Wilkinson KJ. Diffusion of nanoparticles in a biofilm. Environ Sci Technol. 2011;45(8):3367\u201373. https:\/\/doi.org\/10.1021\/es103450g.","journal-title":"Environ Sci Technol"},{"key":"953_CR80","doi-asserted-by":"publisher","unstructured":"Khansa I, Schoenbrunner AR, Kraft CT, Janis JE. Silver in wound care-friend or foe?: a comprehensive review. Plast Reconstr Surg Glob Open. 2019;7(8):e2390. Published 2019 Aug 12. https:\/\/doi.org\/10.1097\/GOX.0000000000002390.","DOI":"10.1097\/GOX.0000000000002390"},{"issue":"2","key":"953_CR81","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/DER.0b013e318284d9f2","volume":"24","author":"R Renner","year":"2013","unstructured":"Renner R, Simon JC, Treudler R. Contact sensitization to modern wound dressings in 70 patients with chronic leg ulcers. Dermatitis. 2013;24(2):60\u20133. https:\/\/doi.org\/10.1097\/DER.0b013e318284d9f2.","journal-title":"Dermatitis"},{"issue":"4","key":"953_CR82","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.jaad.2015.03.059","volume":"74","author":"A Alavi","year":"2016","unstructured":"Alavi A, Sibbald RG, Phillips TJ, et al. What\u2019s new: management of venous leg ulcers: treating venous leg ulcers. J Am Acad Dermatol. 2016;74(4):643\u201366. https:\/\/doi.org\/10.1016\/j.jaad.2015.03.059.","journal-title":"J Am Acad Dermatol"},{"issue":"16","key":"953_CR83","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.3390\/w13162216","volume":"13","author":"M Zahoor","year":"2021","unstructured":"Zahoor M, Nazir N, Iftikhar M, et al. A review on silver nanoparticles: classification, various methods of synthesis, and their potential roles in biomedical applications and water treatment. Water. 2021;13(16):2216. https:\/\/doi.org\/10.3390\/w13162216.","journal-title":"Water"},{"issue":"4","key":"953_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5604\/01.3001.0016.1101","volume":"95","author":"K Phatanodom","year":"2022","unstructured":"Phatanodom K, Angthong C. Silver nanoparticle-based dressings for various wounds: benefits and adverse effects. Pol Przegl Chir. 2022;95(4):1\u20135. https:\/\/doi.org\/10.5604\/01.3001.0016.1101.","journal-title":"Pol Przegl Chir"},{"key":"953_CR85","doi-asserted-by":"publisher","unstructured":"Vermeulen H, van Hattem JM, Storm-Versloot MN, Ubbink DT. Topical silver for treating infected wounds. Cochrane Database Syst Rev. 2007;(1):CD005486. Published 2007 Jan 24. https:\/\/doi.org\/10.1002\/14651858.CD005486.pub2.","DOI":"10.1002\/14651858.CD005486.pub2"},{"issue":"2","key":"953_CR86","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1524-475X.2007.00201.x","volume":"15","author":"H Chambers","year":"2007","unstructured":"Chambers H, Dumville JC, Cullum N. Silver treatments for leg ulcers: a systematic review. Wound Repair Regen. 2007;15(2):165\u201373. https:\/\/doi.org\/10.1111\/j.1524-475X.2007.00201.x.","journal-title":"Wound Repair Regen"},{"issue":"3","key":"953_CR87","doi-asserted-by":"publisher","first-page":"238","DOI":"10.12968\/jowc.2021.30.3.238","volume":"30","author":"R Norton","year":"2021","unstructured":"Norton R, Finley PJ. Clinically isolated bacteria resistance to silver-based wound dressings. J Wound Care. 2021;30(3):238\u201347. https:\/\/doi.org\/10.12968\/jowc.2021.30.3.238.","journal-title":"J Wound Care"},{"key":"953_CR88","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jss.2017.03.040","volume":"215","author":"HZ Li","year":"2017","unstructured":"Li HZ, Zhang L, Chen JX, Zheng Y, Zhu XN. Silver-containing dressing for surgical site infection in clean and clean-contaminated operations: a systematic review and meta-analysis of randomized controlled trials. J Surg Res. 2017;215:98\u2013107. https:\/\/doi.org\/10.1016\/j.jss.2017.03.040.","journal-title":"J Surg Res"},{"key":"953_CR89","doi-asserted-by":"publisher","unstructured":"Gorel O, Hamuda M, Feldman I, Kucyn-Gabovich I. Enhanced healing of wounds that responded poorly to silver dressing by copper wound dressings: prospective single arm treatment study. Health Sci Rep. 2024;7(1):e1816. Published 2024 Jan 14. https:\/\/doi.org\/10.1002\/hsr2.1816.","DOI":"10.1002\/hsr2.1816"},{"issue":"2","key":"953_CR90","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/SAP.0b013e3181893825","volume":"63","author":"G Gravante","year":"2009","unstructured":"Gravante G, Caruso R, Sorge R, Nicoli F, Gentile P, Cervelli V. Nanocrystalline silver: a systematic review of randomized trials conducted on burned patients and an evidence-based assessment of potential advantages over older silver formulations. Ann Plast Surg. 2009;63(2):201\u20135. https:\/\/doi.org\/10.1097\/SAP.0b013e3181893825.","journal-title":"Ann Plast Surg"},{"issue":"3","key":"953_CR91","doi-asserted-by":"publisher","first-page":"162","DOI":"10.12968\/jowc.2020.29.3.162","volume":"29","author":"J Dissemond","year":"2020","unstructured":"Dissemond J, Dietlein M, Ne\u00dfeler I, et al. Use of a TLC-Ag dressing on 2270 patients with wounds at risk or with signs of local infection: an observational study. J Wound Care. 2020;29(3):162\u201373. https:\/\/doi.org\/10.12968\/jowc.2020.29.3.162.","journal-title":"J Wound Care"},{"issue":"4","key":"953_CR92","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1080\/09546634.2017.1385719","volume":"29","author":"A Alavi","year":"2018","unstructured":"Alavi A, Sibbald RG, Kirsner RS. Optimal hidradenitis suppurativa topical treatment and wound care management: a revised algorithm. J Dermatol Treat. 2018;29(4):383\u20134. https:\/\/doi.org\/10.1080\/09546634.2017.1385719.","journal-title":"J Dermatol Treat"},{"issue":"2","key":"953_CR93","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.jaad.2021.09.058","volume":"86","author":"C Schneider","year":"2022","unstructured":"Schneider C, Sanchez DP, MacQuhae F, Stratman S, Lev-Tov H. Wound dressings improve quality of life for hidradenitis suppurativa patients. J Am Acad Dermatol. 2022;86(2):450\u20133. https:\/\/doi.org\/10.1016\/j.jaad.2021.09.058. (Epub 2021 Oct 2 PMID: 34610381).","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"953_CR94","doi-asserted-by":"publisher","first-page":"1527654","DOI":"10.1080\/20016689.2018.1527654","volume":"6","author":"M Gueltzow","year":"2018","unstructured":"Gueltzow M, Khalilpour P, Kolbe K, Zoellner Y. Budget impact of antimicrobial wound dressings in the treatment of venous leg ulcers in the German outpatient care sector: a budget impact analysis. J Mark Access Health Policy. 2018;6(1):1527654\u2013711. https:\/\/doi.org\/10.1080\/20016689.2018.1527654.","journal-title":"J Mark Access Health Policy"},{"key":"953_CR95","doi-asserted-by":"publisher","unstructured":"Kim H, Makin I, Skiba J, et al. Antibacterial efficacy testing of a bioelectric wound dressing against clinical wound pathogens. Open Microbiol J. 2014;8:15\u201321. Published 2014 Feb 21. https:\/\/doi.org\/10.2174\/1874285801408010015.","DOI":"10.2174\/1874285801408010015"},{"issue":"3","key":"953_CR96","doi-asserted-by":"publisher","first-page":"AB129","DOI":"10.1016\/j.jaad.2023.07.517","volume":"89","author":"M Yaghi","year":"2023","unstructured":"Yaghi M, Maskan N, Hargis A, Chopra D, Lev-Tov H. A bioelectric dressing for post de-roofing treatment of hidradenitis suppurativa (HS). J Am Acad Dermatol. 2023;89(3):AB129.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"953_CR97","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/iwj.13093","volume":"16","author":"SL Percival","year":"2019","unstructured":"Percival SL, Mayer D, Kirsner RS, et al. Surfactants: role in biofilm management and cellular behaviour. Int Wound J. 2019;16(3):753\u201360. https:\/\/doi.org\/10.1111\/iwj.13093.","journal-title":"Int Wound J"},{"issue":"5","key":"953_CR98","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1093\/jbcr\/irx041","volume":"39","author":"Q Yang","year":"2018","unstructured":"Yang Q, Schultz GS, Gibson DJ. A surfactant-based dressing to treat and prevent Acinetobacter baumannii biofilms. J Burn Care Res. 2018;39(5):766\u201370. https:\/\/doi.org\/10.1093\/jbcr\/irx041.","journal-title":"J Burn Care Res"},{"issue":"6","key":"953_CR99","first-page":"34","volume":"33","author":"A Gillies","year":"2019","unstructured":"Gillies A. Surfactants in the treatment of chronic wounds and biofilm management. J Community Nurs. 2019;33(6):34\u20138.","journal-title":"J Community Nurs"},{"issue":"4","key":"953_CR100","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/iwj.13546","volume":"18","author":"M Malone","year":"2021","unstructured":"Malone M, Radzieta M, Schwarzer S, Jensen SO, Lavery LA. Efficacy of a topical concentrated surfactant gel on microbial communities in non-healing diabetic foot ulcers with chronic biofilm infections: a proof-of-concept study. Int Wound J. 2021;18(4):457\u201366. https:\/\/doi.org\/10.1111\/iwj.13546.","journal-title":"Int Wound J"},{"issue":"1","key":"953_CR101","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jvn.2017.09.001","volume":"36","author":"CR Ratliff","year":"2018","unstructured":"Ratliff CR. Case series of 18 patients with lower extremity wounds treated with a concentrated surfactant-based gel dressing. J Vasc Nurs. 2018;36(1):3\u20137. https:\/\/doi.org\/10.1016\/j.jvn.2017.09.001.","journal-title":"J Vasc Nurs"},{"issue":"10","key":"953_CR102","doi-asserted-by":"publisher","first-page":"664","DOI":"10.12968\/jowc.2018.27.10.664","volume":"27","author":"K Woo","year":"2018","unstructured":"Woo K, Hill R, LeBlanc K, et al. Effect of a surfactant-based gel on patient quality of life. J Wound Care. 2018;27(10):664\u201378. https:\/\/doi.org\/10.12968\/jowc.2018.27.10.664.","journal-title":"J Wound Care"},{"issue":"Sup4b","key":"953_CR103","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.12968\/jowc.2023.32.Sup4b.S1","volume":"32","author":"S Wu","year":"2023","unstructured":"Wu S, Carter M, Cole W, et al. Best practice for wound repair and regeneration use of cellular, acellular and matrix-like products (CAMPs). J Wound Care. 2023;32(Sup4b):S1\u201331. https:\/\/doi.org\/10.12968\/jowc.2023.32.Sup4b.S1.","journal-title":"J Wound Care"},{"key":"953_CR104","doi-asserted-by":"publisher","unstructured":"Langer A, Rogowski W. Systematic review of economic evaluations of human cell-derived wound care products for the treatment of venous leg and diabetic foot ulcers. BMC Health Serv Res. 2009;9:115. Published 2009 Jul 10. https:\/\/doi.org\/10.1186\/1472-6963-9-115.","DOI":"10.1186\/1472-6963-9-115"},{"key":"953_CR105","doi-asserted-by":"crossref","unstructured":"Veves A, Falanga V, Armstrong DG, Sabolinski ML, Apligraf Diabetic Foot Ulcer S. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care. 2001;24(2):290\u20135.","DOI":"10.2337\/diacare.24.2.290"},{"issue":"4","key":"953_CR106","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1046\/j.1524-475X.1999.00201.x","volume":"7","author":"V Falanga","year":"1999","unstructured":"Falanga V, Sabolinski M. A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers. Wound Repair Regen. 1999;7(4):201\u20137.","journal-title":"Wound Repair Regen"},{"issue":"1","key":"953_CR107","first-page":"57","volume":"17","author":"PJ Kallis","year":"2018","unstructured":"Kallis PJ, Friedman AJ, Lev-Tov H. A guide to tissue-engineered skin substitutes. J Drugs Dermatol. 2018;17(1):57\u201364.","journal-title":"J Drugs Dermatol"},{"issue":"371","key":"953_CR108","doi-asserted-by":"publisher","first-page":"eaaf8611","DOI":"10.1126\/scitranslmed.aaf8611","volume":"9","author":"RC Stone","year":"2017","unstructured":"Stone RC, Stojadinovic O, Rosa AM, et al. A bioengineered living cell construct activates an acute wound healing response in venous leg ulcers. Sci Transl Med. 2017;9(371):eaaf8611. https:\/\/doi.org\/10.1126\/scitranslmed.aaf8611.","journal-title":"Sci Transl Med"},{"issue":"10","key":"953_CR109","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1001\/archderm.136.10.1225","volume":"136","author":"AF Falabella","year":"2000","unstructured":"Falabella AF, Valencia IC, Eaglstein WH, Schachner LA. Tissue-engineered skin (Apligraf) in the healing of patients with epidermolysis bullosa wounds. Arch Dermatol. 2000;136(10):1225\u201330. https:\/\/doi.org\/10.1001\/archderm.136.10.1225.","journal-title":"Arch Dermatol"},{"issue":"5","key":"953_CR110","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/01.ASW.0000397898.56121.3f","volume":"24","author":"G Duchini","year":"2011","unstructured":"Duchini G, Itin P, Arnold A. A case of refractory pyoderma gangrenosum treated with a combination of Apligraf and systemic immunosuppressive agents. Adv Skin Wound Care. 2011;24(5):217\u201320. https:\/\/doi.org\/10.1097\/01.ASW.0000397898.56121.3f.","journal-title":"Adv Skin Wound Care"},{"key":"953_CR111","doi-asserted-by":"publisher","unstructured":"Mostow EN, Haraway GD, Dalsing M, Hodde JP, King D; OASIS Venus Ulcer Study Group. Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial. J Vasc Surg. 2005;41(5):837\u201343. https:\/\/doi.org\/10.1016\/j.jvs.2005.01.042.","DOI":"10.1016\/j.jvs.2005.01.042"},{"issue":"12","key":"953_CR112","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1089\/wound.2015.0645","volume":"4","author":"SM Cazzell","year":"2015","unstructured":"Cazzell SM, Lange DL, Dickerson JE Jr, Slade HB. The management of diabetic foot ulcers with porcine small intestine submucosa tri-layer matrix: a randomized controlled trial. Adv Wound Care (New Rochelle). 2015;4(12):711\u20138.","journal-title":"Adv Wound Care (New Rochelle)"},{"issue":"8","key":"953_CR113","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/term.2884","volume":"13","author":"CN Tchanque-Fossuo","year":"2019","unstructured":"Tchanque-Fossuo CN, Dahle SE, Lev-Tov H, et al. Cellular versus acellular matrix devices in the treatment of diabetic foot ulcers: interim results of a comparative efficacy randomized controlled trial. J Tissue Eng Regen Med. 2019;13(8):1430\u20137. https:\/\/doi.org\/10.1002\/term.2884.","journal-title":"J Tissue Eng Regen Med"},{"key":"953_CR114","doi-asserted-by":"publisher","unstructured":"Serena TE, Carter MJ, Le LT, Sabo MJ, DiMarco DT; EpiFix VLU Study Group. A multicenter, randomized, controlled clinical trial evaluating the use of dehydrated human amnion\/chorion membrane allografts and multilayer compression therapy vs. multilayer compression therapy alone in the treatment of venous leg ulcers. Wound Repair Regen. 2014;22(6):688\u201393. https:\/\/doi.org\/10.1111\/wrr.12227.","DOI":"10.1111\/wrr.12227"},{"issue":"2","key":"953_CR115","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/iwj.12242","volume":"11","author":"CM Zelen","year":"2014","unstructured":"Zelen CM, Serena TE, Snyder RJ. A prospective, randomised comparative study of weekly versus biweekly application of dehydrated human amnion\/chorion membrane allograft in the management of diabetic foot ulcers. Int Wound J. 2014;11(2):122\u20138. https:\/\/doi.org\/10.1111\/iwj.12242.","journal-title":"Int Wound J"},{"issue":"9","key":"953_CR116","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1089\/wound.2015.0647","volume":"4","author":"GW Gibbons","year":"2015","unstructured":"Gibbons GW. Grafix\u00ae, a cryopreserved placental membrane, for the treatment of chronic\/stalled wounds. Adv Wound Care (New Rochelle). 2015;4(9):534\u201344. https:\/\/doi.org\/10.1089\/wound.2015.0647.","journal-title":"Adv Wound Care (New Rochelle)."},{"issue":"5","key":"953_CR117","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/iwj.12329","volume":"11","author":"LA Lavery","year":"2014","unstructured":"Lavery LA, Fulmer J, Shebetka KA, et al. The efficacy and safety of Grafix(\u00ae) for the treatment of chronic diabetic foot ulcers: results of a multi-centre, controlled, randomised, blinded, clinical trial. Int Wound J. 2014;11(5):554\u201360. https:\/\/doi.org\/10.1111\/iwj.12329.","journal-title":"Int Wound J"},{"key":"953_CR118","doi-asserted-by":"publisher","unstructured":"Wisco OJ. Case series: the use of a dehydrated human amnion\/chorion membrane allograft to enhance healing in the repair of lower eyelid defects after Mohs micrographic surgery. JAAD Case Rep. 2016;2(4):294\u20137. Published 2016 Jul 27. https:\/\/doi.org\/10.1016\/j.jdcr.2016.06.002.","DOI":"10.1016\/j.jdcr.2016.06.002"},{"key":"953_CR119","doi-asserted-by":"publisher","unstructured":"Lyons AB, Chipps LK, Moy RL, Herrmann JL. Dehydrated human amnion\/chorion membrane allograft as an aid for wound healing in patients with full-thickness scalp defects after Mohs micrographic surgery. JAAD Case Rep. 2018;4(7):688\u201391. Published 2018 Aug 15. https:\/\/doi.org\/10.1016\/j.jdcr.2018.03.015.","DOI":"10.1016\/j.jdcr.2018.03.015"},{"issue":"1","key":"953_CR120","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00403-022-02327-1","volume":"315","author":"KW Lu","year":"2023","unstructured":"Lu KW, Khachemoune A. Skin substitutes for the management of mohs micrographic surgery wounds: a systematic review. Arch Dermatol Res. 2023;315(1):17\u201331. https:\/\/doi.org\/10.1007\/s00403-022-02327-1.","journal-title":"Arch Dermatol Res"},{"key":"953_CR121","unstructured":"Snyder D, Sullivan N, Margolis D, et al. Skin substitutes for treating chronic wounds [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2020. Appendix D, Commercially Available Skin Substitute Products. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK554211\/."},{"issue":"9","key":"953_CR122","doi-asserted-by":"publisher","first-page":"688","DOI":"10.12968\/jowc.2024.0195","volume":"33","author":"R Snyder","year":"2024","unstructured":"Snyder R, Nouvong A, Ulloa J, et al. Efficacy and safety of autologous whole blood clot in diabetic foot ulcers: a randomised controlled trial. J Wound Care. 2024;33(9):688\u2013700. https:\/\/doi.org\/10.12968\/jowc.2024.0195.","journal-title":"J Wound Care"},{"issue":"Sup2","key":"953_CR123","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.12968\/jowc.2023.32.Sup2.S4","volume":"32","author":"M Gurevich","year":"2023","unstructured":"Gurevich M, Heinz SM, Fridman R, Hawkins J, Wachuku CD. Use of autologous whole blood clot in the treatment of complex surgical wounds: a case series. J Wound Care. 2023;32(Sup2):S4\u20139. https:\/\/doi.org\/10.12968\/jowc.2023.32.Sup2.S4.","journal-title":"J Wound Care"},{"issue":"3","key":"953_CR124","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/iwj.13293","volume":"17","author":"PD Hayes","year":"2020","unstructured":"Hayes PD, Harding KG, Johnson SM, et al. A pilot multi-centre prospective randomised controlled trial of RECELL for the treatment of venous leg ulcers. Int Wound J. 2020;17(3):742\u201352. https:\/\/doi.org\/10.1111\/iwj.13293.","journal-title":"Int Wound J"},{"issue":"1","key":"953_CR125","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/iwj.12047","volume":"12","author":"B De Angelis","year":"2015","unstructured":"De Angelis B, Migner A, Lucarini L, Agovino A, Cervelli V. The use of a non cultured autologous cell suspension to repair chronic ulcers. Int Wound J. 2015;12(1):32\u20139. https:\/\/doi.org\/10.1111\/iwj.12047.","journal-title":"Int Wound J"},{"issue":"10 Suppl","key":"953_CR126","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.12968\/jowc.2013.22.Sup1.S10","volume":"22","author":"H Chant","year":"2013","unstructured":"Chant H, Woodrow T, Manley J. Autologous skin cells: a new technique for skin regeneration in diabetic and vascular ulcers. J Wound Care. 2013;22(10 Suppl):S11\u20135. https:\/\/doi.org\/10.12968\/jowc.2013.22.Sup1.S10.","journal-title":"J Wound Care"},{"issue":"5","key":"953_CR127","doi-asserted-by":"publisher","first-page":"627","DOI":"10.5999\/aps.2013.40.5.627","volume":"40","author":"O Gilleard","year":"2013","unstructured":"Gilleard O, Segaren N, Healy C. Experience of ReCell in skin cancer reconstruction. Arch Plast Surg. 2013;40(5):627\u20139. https:\/\/doi.org\/10.5999\/aps.2013.40.5.627.","journal-title":"Arch Plast Surg"},{"key":"953_CR128","unstructured":"U.S. Food and Drug Administration. RECELL\u00ae autologous cell harvesting device procedure guide. FDA; 2018. https:\/\/www.fda.gov\/media\/116368\/download. Accessed 3 Feb 2025."},{"issue":"3","key":"953_CR129","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1046\/j.1524-475x.2000.00162","volume":"8","author":"JM Embil","year":"2000","unstructured":"Embil JM, Papp K, Sibbald G, et al. Recombinant human platelet-derived growth factor-BB (becaplermin) for healing chronic lower extremity diabetic ulcers: an open-label clinical evaluation of efficacy. Wound Repair Regen. 2000;8(3):162\u20138. https:\/\/doi.org\/10.1046\/j.1524-475x.2000.00162.","journal-title":"Wound Repair Regen"},{"key":"953_CR130","unstructured":"WoundSource. Regranex (Becaplermin) Gel 0.01%. https:\/\/www.woundsource.com\/product\/regranex-becaplermin-gel-001. Accessed 1 Feb 2025."},{"issue":"6","key":"953_CR131","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1067\/mjd.2001.117721","volume":"45","author":"MA Cohen","year":"2001","unstructured":"Cohen MA, Eaglstein WH. Recombinant human platelet-derived growth factor gel speeds healing of acute full-thickness punch biopsy wounds. J Am Acad Dermatol. 2001;45(6):857\u201362. https:\/\/doi.org\/10.1067\/mjd.2001.117721.","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"953_CR132","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.metabol.2014.06.005","volume":"63","author":"XH Zhao","year":"2014","unstructured":"Zhao XH, Gu HF, Xu ZR, Zhang Q, Lv XY, Zheng XJ, Yang YM. Efficacy of topical recombinant human platelet-derived growth factor for treatment of diabetic lower-extremity ulcers: systematic review and meta-analysis. Metabolism. 2014;63(10):1304\u201313. https:\/\/doi.org\/10.1016\/j.metabol.2014.06.005. (Epub 2014 Jun 13 PMID: 25060693).","journal-title":"Metabolism"},{"issue":"8","key":"953_CR133","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1007\/s00268-009-0046-y","volume":"33","author":"M Spyridakis","year":"2009","unstructured":"Spyridakis M, Christodoulidis G, Chatzitheofilou C, Symeonidis D, Tepetes K. The role of the platelet-rich plasma in accelerating the wound-healing process and recovery in patients being operated for pilonidal sinus disease: preliminary results. World J Surg. 2009;33(8):1764\u20139. https:\/\/doi.org\/10.1007\/s00268-009-0046-y.","journal-title":"World J Surg"},{"key":"953_CR134","doi-asserted-by":"publisher","unstructured":"Meznerics FA, Feh\u00e9rv\u00e1ri P, Dembrovszky F, et al. Platelet-rich plasma in chronic wound management: a systematic review and meta-analysis of randomized clinical trials. J Clin Med. 2022;11(24):7532. Published 2022 Dec 19. https:\/\/doi.org\/10.3390\/jcm11247532.","DOI":"10.3390\/jcm11247532"},{"issue":"9","key":"953_CR135","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1016\/j.mayocp.2021.01.030","volume":"96","author":"W Qu","year":"2021","unstructured":"Qu W, Wang Z, Hunt C, et al. The effectiveness and safety of platelet-rich plasma for chronic wounds: a systematic review and meta-analysis. Mayo Clin Proc. 2021;96(9):2407\u201317. https:\/\/doi.org\/10.1016\/j.mayocp.2021.01.030.","journal-title":"Mayo Clin Proc"},{"key":"953_CR136","doi-asserted-by":"publisher","unstructured":"Bray ER, Oropallo AR, Grande DA, Kirsner RS, Badiavas EV. Extracellular vesicles as therapeutic tools for the treatment of chronic wounds. Pharmaceutics. 2021;13(10):1543\u2013. https:\/\/doi.org\/10.3390\/pharmaceutics13101543.","DOI":"10.3390\/pharmaceutics13101543"},{"key":"953_CR137","doi-asserted-by":"publisher","unstructured":"Gunjan, Himanshu, Pandey RP, Mukherjee R, Chang CM. Advanced meta-analysis on therapeutic strategies of mesenchymal derived exosome for diabetic chronic wound healing and tissue remodeling. Mol Cell Probes. 2024;77:101974. https:\/\/doi.org\/10.1016\/j.mcp.2024.101974.","DOI":"10.1016\/j.mcp.2024.101974"},{"key":"953_CR138","doi-asserted-by":"publisher","unstructured":"Y\u00e1\u00f1ez-M\u00f3 M, Siljander PRM, Andreu Z, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4(1):27066\u2013n\/a. https:\/\/doi.org\/10.3402\/jev.v4.27066.","DOI":"10.3402\/jev.v4.27066"},{"key":"953_CR139","unstructured":"U.S. Food and Drug Administration. Consumer alert: regenerative medicine products, including stem cells and exosomes. Published April 9, 2024. https:\/\/www.fda.gov\/vaccines-blood-biologics\/consumers-biologics\/consumer-alert-regenerative-medicine-products-including-stem-cells-and-exosomes. Accessed 2 Feb 2025."},{"issue":"7","key":"953_CR140","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12332","volume":"12","author":"J Johnson","year":"2023","unstructured":"Johnson J, Law SQK, Shojaee M, et al. First-in-human clinical trial of allogeneic, platelet-derived extracellular vesicles as a potential therapeutic for delayed wound healing. J Extracell Vesicles. 2023;12(7): e12332. https:\/\/doi.org\/10.1002\/jev2.12332.","journal-title":"J Extracell Vesicles"},{"key":"953_CR141","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106718","volume":"190","author":"L Gibello","year":"2023","unstructured":"Gibello L, D\u2019Antico S, Salafia M, et al. First pilot case-control interventional study using autologous extracellular vesicles to treat chronic venous ulcers unresponsive to conventional treatments. Pharmacol Res. 2023;190: 106718. https:\/\/doi.org\/10.1016\/j.phrs.2023.106718.","journal-title":"Pharmacol Res"},{"issue":"7","key":"953_CR142","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12458","volume":"13","author":"M Van Delen","year":"2024","unstructured":"Van Delen M, Derdelinckx J, Wouters K, Nelissen I, Cools N. A systematic review and meta-analysis of clinical trials assessing safety and efficacy of human extracellular vesicle-based therapy. J Extracell Vesicles. 2024;13(7): e12458. https:\/\/doi.org\/10.1002\/jev2.12458.","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"953_CR143","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/wrr.12871","volume":"29","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Chia HWA, Tang HWK, et al. Efficacy of low-level light therapy for improving healing of diabetic foot ulcers: a systematic review and meta-analysis of randomized controlled trials. Wound Repair Regen. 2021;29(1):34\u201344. https:\/\/doi.org\/10.1111\/wrr.12871.","journal-title":"Wound Repair Regen"},{"issue":"5","key":"953_CR144","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jaad.2023.10.073","volume":"91","author":"J Maghfour","year":"2024","unstructured":"Maghfour J, Ozog DM, Mineroff J, Jagdeo J, Kohli I, Lim HW. Photobiomodulation CME part I: overview and mechanism of action. J Am Acad Dermatol. 2024;91(5):793\u2013802. https:\/\/doi.org\/10.1016\/j.jaad.2023.10.073.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"953_CR145","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1177\/1534734620914439","volume":"20","author":"CM dos Santos","year":"2021","unstructured":"dos Santos CM, da Rocha RB, Hazime FA, Cardoso VS. A systematic review and meta-analysis of the effects of low-level laser therapy in the treatment of diabetic foot ulcers. Int J Low Extrem Wounds. 2021;20(3):198\u2013207. https:\/\/doi.org\/10.1177\/1534734620914439.","journal-title":"Int J Low Extrem Wounds"},{"issue":"2","key":"953_CR146","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s10103-016-2109-2","volume":"32","author":"RK Mathur","year":"2017","unstructured":"Mathur RK, Sahu K, Saraf S, Patheja P, Khan F, Gupta PK. Low-level laser therapy as an adjunct to conventional therapy in the treatment of diabetic foot ulcers. Lasers Med Sci. 2017;32(2):275\u201382. https:\/\/doi.org\/10.1007\/s10103-016-2109-2.","journal-title":"Lasers Med Sci"},{"key":"953_CR147","doi-asserted-by":"publisher","unstructured":"Borges NCS, Soares LR, Perissini MM, et al. Photobiomodulation using red and infrared spectrum light emitting-diode (LED) for the healing of diabetic foot ulcers: a controlled randomized clinical trial. Lasers Med Sci. 2024;39(1):253. Published 2024 Oct 9. https:\/\/doi.org\/10.1007\/s10103-024-04199-5.","DOI":"10.1007\/s10103-024-04199-5"},{"key":"953_CR148","doi-asserted-by":"publisher","unstructured":"Li M, Wang C, Yu Q, et al. A wearable and stretchable dual-wavelength LED device for home care of chronic infected wounds. Nat Commun. 2024;15(1):9380. Published 2024 Oct 30. https:\/\/doi.org\/10.1038\/s41467-024-53579-6.","DOI":"10.1038\/s41467-024-53579-6"},{"key":"953_CR149","doi-asserted-by":"publisher","unstructured":"Ud-Din S, Bayat A. Electrical stimulation and cutaneous wound healing: a review of clinical evidence. Healthcare (Basel). 2014;2(4):445\u201367. Published 2014 Oct 27. https:\/\/doi.org\/10.3390\/healthcare2040445.","DOI":"10.3390\/healthcare2040445"},{"issue":"5","key":"953_CR150","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.jvsv.2023.05.005","volume":"11","author":"D Borges","year":"2023","unstructured":"Borges D, Pires R, Ferreira J, Dias-Neto M. The effect of wound electrical stimulation in venous leg ulcer healing\u2014a systematic review. J Vasc Surg Venous Lymphat Disord (New York, NY). 2023;11(5):1070-1079.e1. https:\/\/doi.org\/10.1016\/j.jvsv.2023.05.005.","journal-title":"J Vasc Surg Venous Lymphat Disord (New York, NY)"},{"issue":"3","key":"953_CR151","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1089\/rej.2011.1236","volume":"15","author":"A Santamato","year":"2012","unstructured":"Santamato A, Panza F, Fortunato F, et al. Effectiveness of the frequency rhythmic electrical modulation system for the treatment of chronic and painful venous leg ulcers in older adults. Rejuvenation Res. 2012;15(3):281\u20137. https:\/\/doi.org\/10.1089\/rej.2011.1236.","journal-title":"Rejuvenation Res"},{"issue":"7","key":"953_CR152","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00403-008-0875-9","volume":"300","author":"A Jankovic","year":"2008","unstructured":"Jankovic A, Binic I. Frequency rhythmic electrical modulation system in the treatment of chronic painful leg ulcers. Arch Dermatol Res. 2008;300(7):377\u201383. https:\/\/doi.org\/10.1007\/s00403-008-0875-9.","journal-title":"Arch Dermatol Res"},{"issue":"7","key":"953_CR153","first-page":"26","volume":"60","author":"R Dymarek","year":"2014","unstructured":"Dymarek R, Halski T, Ptaszkowski K, Slupska L, Rosinczuk J, Taradaj J. Extracorporeal shock wave therapy as an adjunct wound treatment: a systematic review of the literature. Ostomy Wound Manag. 2014;60(7):26\u201339.","journal-title":"Ostomy Wound Manag"},{"issue":"3","key":"953_CR154","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jamcollsurg.2010.05.012","volume":"211","author":"C Ottomann","year":"2010","unstructured":"Ottomann C, Hartmann B, Tyler J, et al. Prospective randomized trial of accelerated re-epithelization of skin graft donor sites using extracorporeal shock wave therapy. J Am Coll Surg. 2010;211(3):361\u20137. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2010.05.012.","journal-title":"J Am Coll Surg"},{"key":"953_CR155","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-10-54","author":"B Moretti","year":"2009","unstructured":"Moretti B, Notarnicola A, Maggio G, Moretti L, Pascone M, Tafuri S, et al. The management of neuropathic ulcers of the foot in diabetes by shock wave therapy. BMC Musculoskelet Disord. 2009. https:\/\/doi.org\/10.1186\/1471-2474-10-54.","journal-title":"BMC Musculoskelet Disord"},{"issue":"17","key":"953_CR156","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1016\/j.cell.2023.07.031","volume":"186","author":"AL Epstein","year":"2023","unstructured":"Epstein AL, Haag-Molkenteller C. Herpes simplex virus gene therapy for dystrophic epidermolysis bullosa (DEB). Cell. 2023;186(17):3523-3523.e1. https:\/\/doi.org\/10.1016\/j.cell.2023.07.031.","journal-title":"Cell"},{"key":"953_CR157","doi-asserted-by":"publisher","unstructured":"Khan A, Riaz R, Ashraf S, Akilimali A. Revolutionary breakthrough: FDA approves Vyjuvek, the first topical gene therapy for dystrophic epidermolysis bullosa. Ann Med Surg (Lond). 2023;85(12):6298\u2013301. Published 2023 Oct 17. https:\/\/doi.org\/10.1097\/MS9.0000000000001422.","DOI":"10.1097\/MS9.0000000000001422"},{"issue":"24","key":"953_CR158","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1056\/NEJMoa2206663","volume":"387","author":"SV Guide","year":"2022","unstructured":"Guide SV, Gonzalez ME, Ba\u011fc\u0131 IS, et al. Trial of beremagene geperpavec (B-VEC) for dystrophic epidermolysis bullosa. N Engl J Med. 2022;387(24):2211\u20139. https:\/\/doi.org\/10.1056\/NEJMoa2206663.","journal-title":"N Engl J Med"},{"key":"953_CR159","doi-asserted-by":"publisher","unstructured":"Ning P, Liu Y, Kang J, Cao H, Zhang J. Comparison of healing effectiveness of different debridement approaches for diabetic foot ulcers: a network meta-analysis of randomized controlled trials. Front Public Health. 2023;11:1271706. Published 2023 Dec 11. https:\/\/doi.org\/10.3389\/fpubh.2023.1271706.","DOI":"10.3389\/fpubh.2023.1271706"},{"issue":"1","key":"953_CR160","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/wrr.13130","volume":"32","author":"LJ Gould","year":"2024","unstructured":"Gould LJ, Alderden J, Aslam R, et al. WHS guidelines for the treatment of pressure ulcers-2023 update. Wound Repair Regen. 2024;32(1):6\u201333. https:\/\/doi.org\/10.1111\/wrr.13130.","journal-title":"Wound Repair Regen"},{"issue":"2 Suppl","key":"953_CR161","doi-asserted-by":"publisher","first-page":"3S","DOI":"10.1016\/j.jvs.2015.10.003","volume":"63","author":"A Hingorani","year":"2016","unstructured":"Hingorani A, LaMuraglia GM, Henke P, et al. The management of diabetic foot: a clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine. J Vasc Surg. 2016;63(2 Suppl):3S-21S. https:\/\/doi.org\/10.1016\/j.jvs.2015.10.003.","journal-title":"J Vasc Surg"},{"key":"953_CR162","doi-asserted-by":"publisher","unstructured":"Elraiyah T, Domecq JP, Prutsky G, et al. A systematic review and meta-analysis of d\u00e9bridement methods for chronic diabetic foot ulcers. J Vasc Surg. 2016;63(2 Suppl):37S\u201345S.e2. https:\/\/doi.org\/10.1016\/j.jvs.2015.10.002.","DOI":"10.1016\/j.jvs.2015.10.002"},{"issue":"2 Suppl","key":"953_CR163","doi-asserted-by":"publisher","first-page":"3S","DOI":"10.1016\/j.jvs.2014.04.049","volume":"60","author":"TF O\u2019Donnell Jr","year":"2014","unstructured":"O\u2019Donnell TF Jr, Passman MA, Marston WA, et al. Management of venous leg ulcers: clinical practice guidelines of the Society for Vascular Surgery \u00ae and the American Venous Forum. J Vasc Surg. 2014;60(2 Suppl):3S-59S. https:\/\/doi.org\/10.1016\/j.jvs.2014.04.049.","journal-title":"J Vasc Surg"},{"issue":"6","key":"953_CR164","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1111\/iwj.12760","volume":"14","author":"J Patry","year":"2017","unstructured":"Patry J, Blanchette V. Enzymatic debridement with collagenase in wounds and ulcers: a systematic review and meta-analysis. Int Wound J. 2017;14(6):1055\u201365. https:\/\/doi.org\/10.1111\/iwj.12760.","journal-title":"Int Wound J"},{"issue":"2","key":"953_CR165","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1067-1927.2005.130203.x","volume":"13","author":"D Williams","year":"2005","unstructured":"Williams D, Enoch S, Miller D, Harris K, Price P, Harding KG. Effect of sharp debridement using curette on recalcitrant nonhealing venous leg ulcers: a concurrently controlled, prospective cohort study. Wound Repair Regen. 2005;13(2):131\u20137. https:\/\/doi.org\/10.1111\/j.1067-1927.2005.130203.x.","journal-title":"Wound Repair Regen"},{"key":"953_CR166","unstructured":"WoundSource. Apligraf. https:\/\/www.woundsource.com\/product\/apligraf. Accessed 1 Feb 2025."},{"key":"953_CR167","unstructured":"WoundSource. Oasis. https:\/\/www.woundsource.com\/product\/oasis-wound-matrix. Accessed 1 Feb 2025."},{"key":"953_CR168","unstructured":"WoundSource. ActiGraft Pro System. https:\/\/www.woundsource.com\/product\/actigraft-pro-system. Accessed 1 Feb 2025."},{"issue":"6","key":"953_CR169","doi-asserted-by":"publisher","DOI":"10.1111\/srt.13820","volume":"30","author":"J Lou","year":"2024","unstructured":"Lou J, Xiang Z, Fan Y, et al. The efficacy and safety of autologous epidermal cell suspensions for re-epithelialization of skin lesions: a systematic review and meta-analysis of randomized trials. Skin Res Technol. 2024;30(6): e13820. https:\/\/doi.org\/10.1111\/srt.13820.","journal-title":"Skin Res Technol"},{"key":"953_CR170","doi-asserted-by":"publisher","unstructured":"Holmes JH. A brief history of RECELL\u00ae and its current indications. J Burn Care Res. 2023;44(Suppl_1):S48\u20139. https:\/\/doi.org\/10.1093\/jbcr\/irac121.","DOI":"10.1093\/jbcr\/irac121"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-025-00953-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-025-00953-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-025-00953-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T20:02:48Z","timestamp":1757966568000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-025-00953-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":170,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["953"],"URL":"https:\/\/doi.org\/10.1007\/s40257-025-00953-9","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,11]]},"assertion":[{"value":"12 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that no funding was received for this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors report no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Many of the manuscripts are publicly available, with some requiring access to the journal in which it was published.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable to this work.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable to this work.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable to this work.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable to this work.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of code"}},{"value":"All authors have made contributions to the content, writing, and editing of this manuscript and have reviewed and approved the final version.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}